Mochizuki T, Muto S, Suzue K, Komaniwa S, Tanaka T, Fukuta Y
Clin Exp Nephrol. 2025; .
PMID: 39953249
DOI: 10.1007/s10157-025-02634-7.
Higashihara E, Matsukawa M, Jiang H
Clin Exp Nephrol. 2025; .
PMID: 39747793
DOI: 10.1007/s10157-024-02589-1.
Lee W, Cheng B, Lee C, Liao S
J Med Ultrasound. 2024; 32(2):110-115.
PMID: 38882609
PMC: 11175384.
DOI: 10.4103/jmu.jmu_77_23.
Roca Oporto F, Andrades Gomez C, Montilla Cosano G, Aguilera A, Rocha J
Kidney Int Rep. 2024; 9(4):1031-1039.
PMID: 38765583
PMC: 11101827.
DOI: 10.1016/j.ekir.2024.01.020.
Ushio Y, Kataoka H, Akagawa H, Sato M, Manabe S, Kawachi K
J Nephrol. 2024; 37(4):983-992.
PMID: 38315279
DOI: 10.1007/s40620-023-01866-8.
Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease.
Kimura T, Kawano H, Muto S, Muramoto N, Takano T, Lu Y
Biomolecules. 2023; 13(7).
PMID: 37509056
PMC: 10377076.
DOI: 10.3390/biom13071020.
A novel splicing variant identified in a fetus with autosomal recessive polycystic kidney disease.
Miao M, Feng L, Wang J, Xu C, Su X, Zhang G
Front Genet. 2023; 14:1207772.
PMID: 37456659
PMC: 10339289.
DOI: 10.3389/fgene.2023.1207772.
Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease.
Kataoka H, Shimada Y, Kimura T, Nishio S, Nakatani S, Mochizuki T
Clin Exp Nephrol. 2023; 27(10):809-818.
PMID: 37368094
DOI: 10.1007/s10157-023-02372-8.
Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease.
Kim Y, Han S
Korean J Intern Med. 2023; 38(3):322-331.
PMID: 37089056
PMC: 10175869.
DOI: 10.3904/kjim.2022.376.
Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease.
Kataoka H, Akagawa H, Yoshida R, Iwasa N, Ushio Y, Akihisa T
Sci Rep. 2022; 12(1):18056.
PMID: 36302803
PMC: 9613770.
DOI: 10.1038/s41598-022-22884-9.
The effect of trichlormethiazide in autosomal dominant polycystic kidney disease patients receiving tolvaptan: a randomized crossover controlled trial.
Uchiyama K, Kitayama C, Yanai A, Ishibashi Y
Sci Rep. 2021; 11(1):17666.
PMID: 34480075
PMC: 8417075.
DOI: 10.1038/s41598-021-97113-w.
'A sword of Damocles': patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group study.
Logeman C, Cho Y, Sautenet B, Rangan G, Gutman T, Craig J
BMJ Open. 2020; 10(10):e038005.
PMID: 33040007
PMC: 7549480.
DOI: 10.1136/bmjopen-2020-038005.
A Woman With "Polycystic Kidney Disease".
Tu Y, Sheng M, Wang Y, Wang Z, Zhang X, Liu B
Kidney Int Rep. 2020; 5(8):1367-1370.
PMID: 32775843
PMC: 7403545.
DOI: 10.1016/j.ekir.2020.05.026.
Collagen-driven remodeling of the intrahepatic duct wall in the PCK rat model of polycystic kidney disease-Caroli syndrome.
Narayan R, Li J, Pellicano A, Goldberg I
Clin Exp Hepatol. 2020; 6(2):131-136.
PMID: 32728630
PMC: 7380478.
DOI: 10.5114/ceh.2020.95529.
Successful Treatment of Cyst Infection in an Infant With Autosomal Dominant Polycystic Kidney Disease Using Trimethoprim/Sulfamethoxazole.
Yokoyama H, Sakaguchi M, Yamada Y, Kitamoto K, Okada S, Kanzaki S
Front Pediatr. 2020; 8:216.
PMID: 32582581
PMC: 7280440.
DOI: 10.3389/fped.2020.00216.
Non-compaction of ventricular myocardium with polycystic kidney disease with cardiogenic cerebral embolism.
Rani M, Rajput R, Mishra S, Garg R
BMJ Case Rep. 2020; 13(1).
PMID: 31974261
PMC: 7021183.
DOI: 10.1136/bcr-2019-232458.
Role of Liver Transplantation in Tolvaptan-Associated Acute Liver Failure.
Endo M, Katayama K, Matsuo H, Horiike S, Nomura S, Hayashi A
Kidney Int Rep. 2020; 4(11):1653-1657.
PMID: 31891010
PMC: 6933473.
DOI: 10.1016/j.ekir.2019.09.002.
Kidney transplant patient with immunoglobulin A nephropathy subsequently diagnosed as concurrent autosomal dominant polycystic kidney disease during 17-year follow-up.
Usui J, Kai H, Kaneko S, Takahashi-Kobayashi M, Hagiwara M, Takahashi K
CEN Case Rep. 2019; 9(2):106-108.
PMID: 31792758
PMC: 7148390.
DOI: 10.1007/s13730-019-00436-x.
Dietary Care for ADPKD Patients: Current Status and Future Directions.
Carriazo S, Perez-Gomez M, Cordido A, Garcia-Gonzalez M, Sanz A, Ortiz A
Nutrients. 2019; 11(7).
PMID: 31336917
PMC: 6683072.
DOI: 10.3390/nu11071576.
Updated Canadian Expert Consensus on Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease.
Soroka S, Alam A, Bevilacqua M, Girard L, Komenda P, Loertscher R
Can J Kidney Health Dis. 2018; 5:2054358118801589.
PMID: 30345064
PMC: 6187423.
DOI: 10.1177/2054358118801589.
